Daneryd P., Aberg F., Dallner G., Ernster L., Schersten T., Soussi B (1995a) Coenzymes Q9 and Q10 in skeletal and cardiac muscle in tumour-bearing exercising rats. European Journal of Cancer 331A, 760-765. |
Daneryd P., Hafstrom L., Svanberg E., Karlberg I (1995b) Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising rats. European Journal of Cancer 31A, 97-103. |
Davies K.J., Quintanilha A.T., Brooks G.A., Packer L (1982) Free radicals and tissue damage produced by exercise. Biochemical Biophysical Researcg Communication 107, 1198-1205. |
Fairey A.S., Courneya K.S., Field C.J., Mackey J.R (2002) Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 994, 539-551. |
Finlay C. A., Hinds P. W., Levine A. J (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 557, 1083-1093. |
Foster B.A., Coffey H.A., Morin M.J., Rastinejad F (1999) Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507-2510. |
Gerber M, Sen C.K.L., Packer L., Hanninen O. (2000) Handbook of Oxidants and Antioxidants in Exercise. Oxidative stress, antioxidants and cancer. Amsterdam. Elsevier Sci. |
Hill M.J (1999) Diet, physical activity and cancer risk. Public Health Nutrition 22, 397-401. |
Inger T., Eiliv L (1997) Exercise and breast cancer. New England Journal of Medicine 337, 708-709. |
Ji L.L (1999) Antioxidants and oxidative stress in exercise. Proceeding Society Experimental Biology and Medicine 222, 283-292. |
Ji L.L., Hollander J, Radak Z (2000) Free Radicals in Exercise and Aging. Antioxidant enzyme defense: effects of aging and exercise. Champaign, IL.. Human Kinetics. |
Kaelin W.G. (1999) The p53 gene family. Oncogene 118, 7701-7705. |
Kiningham R.B (1998) Physical activity and the primary prevention of cancer. Primary Care 225, 515-536. |
Kritchevsky D (2001) Caloric restriction and cancer. Journal of Nutrition Science and Vitaminology (Tokyo) 447, 13-19. |
Lane D.P., Benchimol S (1990) p53: oncogene or anti-oncogene?. Genes Dev 44, 1-8. |
Murphy K.L., Dennis A.P., Rosen J.M (2000) A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB Journal 114, 2291-2302. |
Oren M (1992) p53: the ultimate tumor suppressor gene?. FASEB Journal 66, 3169-3176. |
Radak Z., Asano K., Lee K. C., Ohno H., Nakamura A., Nakamoto H., Goto S (1997) High altitude training increases reactive carbonyl derivatives but not lipid peroxidation in skeletal muscle of rats. Free Radical Biology and Medicine 222, 1109-1114. |
Radak Z., Goto S, Radak Z (2000) Free Radicals in Exercise and Aging. Oxidative modification of proteins and DNA. Champaign, IL.. Human Kinetics. |
Radak Z., Kaneko T., Tahara S., Nakamoto H., Ohno H., Sasvari M., Nyakas C., Goto S (1999) The effect of exercise training on oxidative damage of lipids, proteins, and DNA in rat skeletal muscle: evidence for beneficial outcomes. Free Radical Biology and Medicine 227, 69-74. |
Radak Z., Taylor A. W., Sasvari M., Ohno H., Horkay B., Furesz J., Gaal D., Kanel T (2001) Telomerase activity is not altered by regular strenuous exercise in skeletal muscle or by sarcoma in liver of rats. Redox Report 66, 99-103. |
Shephard R.J., Futcher R (1997) Physical activity and cancer: how may protection be maximized?. Critcal Review of Oncogolgy 88, 219-272. |
Thompson H.J (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Research 554, 1960-. |
Thompson H.J., Westerlind K. C., Snedden J., Briggs S., Singh M (1995) Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 116, 1783-1786. |
Tomayko M.M., Reynolds C.P (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemotherapy and Pharmacology 224, 148-154. |
Wiedmann M.W., Caca K (2005) Molecularly targeted therapy for gastrointestinal cancer. Current Cancer Drug Targets 55, 171-193. |
Wiedmann M.W., Mossner J (2010) Molecular targeted therapy of biliary tract cancer--results of the first clinical studies. Current Cancer Drug Targets 111, 834-850. |
Zhang Z., Li J., Lantry L.E., Wang Y., Wiseman R.W., Lubet R.A., You M (2002) p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas. Cancer Research 662, 3024-3029. |
|